Try our Advanced Search for more refined results
August 04, 2017
In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Case Number:
2:17-md-02785
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Squitieri & Fearon
- Law Offices of Ursula Taylor
- Matthew G. Miller PC
- Spencer Fane
- Berman Tabacco
- Foulston Siefkin
- Sharp Law LLP
- Parker Waichman
- Siegfried & Jensen
- Spragens Law
- Steven Williams Law
- Barnow & Associates
- Goldman Scarlato
- Saiber LLC
- Pritzker Levine
- Berkowitz Oliver
- Baron & Budd
- Barton & Burrows
- Kaufman & Canoles
- Mehri & Skalet
- Beasley Allen
- Blood Hurst
- Lathrop GPM
- Robbins Russell
- Kramer Levin
- King & Spalding
- Perkins Coie
- DiCello Levitt
- Lockridge Grindal
- Yarmuth LLP
- Pallas Partners
- Boies Schiller
- Hagens Berman
- Lightfoot Franklin
- Robbins Geller
- Hinkle Law Firm
- Robins Kaplan
- Carella Byrne
- Burns Charest
- Marion's Inn
- Sidley Austin
- Ali & Lockwood
- Strategic Health Law
- Dollar Burns
- Butler Prather
- Groom Law Group
- Levi & Korsinsky
- Fredrikson & Byron
- Bradford & Wilson
- Gibbons PC
- Williams & Connolly
- Gustafson Gluek
- Reed Smith
- Lanier Law Firm
- Horn Aylward
- Joseph Saveri Law Firm
- Keller Rohrback
- Bush Seyferth
- Wagstaff & Cartmell
- Weil Gotshal
- Gibson Dunn
- Foley & Lardner
- Hogan Lovells
- Shook Hardy
- Holland & Knight
- DLA Piper
- Lowey Dannenberg
- Clark Hill
- Goodwin Procter
- Wilson Sonsini
- GM Law PC
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Amerigroup Corp.
- Change Healthcare Inc.
- MedImpact Healthcare Systems Inc.
- Aetna Inc.
- Meridian Medical Technologies Inc.
- Coventry Health Care Inc.
- The Segal Co. Inc.
- Sanofi
- Optum Inc.
- Express Scripts Holding Co.
- Viatris Inc.
- Humana Inc.
- OptumRx Inc.
- CVS Health Corp.
- Pfizer Inc.
- Blue Cross Blue Shield Association
- Centene Corp.
- King Pharmaceuticals Inc.
- UnitedHealth Group Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 14, 2022
Judge OKs $264M Deal Ending Mylan EpiPen Price-Hike Suit
A Kansas federal court has preliminarily approved a $264 million deal that would end claims that Mylan colluded with Pfizer Inc. to obstruct generic versions of the EpiPen, the emergency drug used to treat severe allergic reactions, from entering the market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login